Finnegan Paul 5
5 · Imprimis Pharmaceuticals, Inc. · Filed Mar 15, 2013
Insider Transaction Report
Form 5
Finnegan Paul
Director
Transactions
- Award
Option (Right to Buy)
2012-02-28+125,000→ 150,000 totalExercise: $3.20Exp: 2017-01-22→ Common Stock (125,000 underlying) - Award
Option (Right to Buy)
2012-04-01+25,000→ 150,000 totalExercise: $4.50Exp: 2017-03-31→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The stock option was granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vests in three equal annual installments beginning on January 6, 2013. The option was approved by the Issuer's Board of Directors on January 23, 2012, subject to shareholder approval of an amendment to the Plan, which was obtained on February 28, 2012.
- [F2]The stock option was granted under the Plan and vests in four equal quarterly installments beginning on June 30, 2012.